GreenLight HPS™ 120‐W laser vaporization vs transurethral resection of the prostate (<60 mL): a 2‐year randomized double‐blind prospective urodynamic investigation

Study Type – Therapy (RCT) Level of Evidence 1b What's known on the subject? and What does the study add? Photovaporization of the prostate (PVP) is now challenging TURP as the standard treatment for lower LUTS caused by BPH. The learning curve for PVP is short and the main advantages of this m...

Full description

Saved in:
Bibliographic Details
Published inBJU international Vol. 110; no. 8; pp. 1184 - 1189
Main Authors Pereira‐Correia, João Antonio, de Moraes Sousa, Karlo Danilson, Santos, João Bosco Pinheiro, de Morais Perpétuo, Daniel, Lopes‐da‐Silva, Luiz Felipe, Krambeck, Renato Lages, Muller, Valter José Fernandes, Vaz, Fernando Pires
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.10.2012
Wiley-Blackwell
Subjects
Online AccessGet full text
ISSN1464-4096
1464-410X
1464-410X
DOI10.1111/j.1464-410X.2011.10878.x

Cover

Abstract Study Type – Therapy (RCT) Level of Evidence 1b What's known on the subject? and What does the study add? Photovaporization of the prostate (PVP) is now challenging TURP as the standard treatment for lower LUTS caused by BPH. The learning curve for PVP is short and the main advantages of this method over TURP are a shorter period of hospitalization, a shorter period of postoperative vesical catheterization, lower levels of retrograde ejaculation, rare development of dilutional hyponatraemia syndrome, the lack of a need for postoperative vesical irrigation as a result of extremely low indices of postoperative haematuria, and the lack of a need to suspend anticoagulant medication for the surgery. Traditionally, comparisons of the effectiveness of TURP vs PVP have involved parameters such as peak flow urinary rate and post‐void residual urine volume measurements, and have employed questionnaires such as the IPSS and the International Index of Erectile Function instruments. However, studies evaluating detailed urodynamic parameters remain scarce and non‐comparative The present study compared postoperative, medium‐term urodynamic parameters among patients receiving TURP and high‐power PVP. We consider the present study to be distinctive because it involved a double‐blind, detailed functional analysis of the vesical emptying stage over the course of 2 years, and did not simply comprise an evaluation of clinical parameters and uroflowmetrics. We saw a reduction of infravesical obstruction, as shown by the significant reduction of ≥20 cm H2O in the mean micturition pressure for the groups studied, as well as a significant reduction in bladder outlet obstruction index. Thus, the present data show that high‐power PVP can achieve and maintain the same results as TURP over a period of 24 months regarding an aspect that is particularly important for maintaining vesical health (i.e. detrusor pressure during the evacuation of the bladder). Such urodynamic data describing the functional outcome of PVP are currently missing from the literature. OBJECTIVE •  To assess the impact of GreenLight HPSTM 120‐W (American Medical System Incorporation, Minnetonka, MN, USA) laser photovaporization of the prostate (PVP) compared to transurethral resection of the prostate (TURP) on urodynamic results, voiding function and sexual function. PATIENTS AND METHODS •  In total, 20 men with intermediate/severe lower urinary tract symptoms as a result of benign prostatic hyperplasia (BPH) were randomly selected and equally divided into two groups: TURP and PVP. •  Urodynamic evaluation was performed and International Prostate Symptom Score (IPSS), International Index of Erectile Function‐5 and International Consultation on Incontinence Questionnaire – Short Form questionnaires were completed. •  The results were assessed at 2 years. RESULTS •  Mean IPSS scores were reduced in both groups, although they did not differ between the TURP and PVP groups. •  There was no significant change in International Index of Erectile Function‐5 scores. •  Half of the patients in the PVP group developed urge urinary incontinence with spontaneous resolution. •  The urodynamic parameters analyzed showed an improvement for both groups, although the values in the TURP group values were not significantly different from those in the PVP group. CONCLUSIONS •  Bladder storage symptoms may represent a major concern, although they are of limited duration in patients undergoing PVP. •  High‐power PVP can achieve and maintain the same results as TURP over a period of 24 months.
AbstractList What's known on the subject? and What does the study add? Photovaporization of the prostate (PVP) is now challenging TURP as the standard treatment for lower LUTS caused by BPH. The learning curve for PVP is short and the main advantages of this method over TURP are a shorter period of hospitalization, a shorter period of postoperative vesical catheterization, lower levels of retrograde ejaculation, rare development of dilutional hyponatraemia syndrome, the lack of a need for postoperative vesical irrigation as a result of extremely low indices of postoperative haematuria, and the lack of a need to suspend anticoagulant medication for the surgery. Traditionally, comparisons of the effectiveness of TURP vs PVP have involved parameters such as peak flow urinary rate and post-void residual urine volume measurements, and have employed questionnaires such as the IPSS and the International Index of Erectile Function instruments. However, studies evaluating detailed urodynamic parameters remain scarce and non-comparative The present study compared postoperative, medium-term urodynamic parameters among patients receiving TURP and high-power PVP. We consider the present study to be distinctive because it involved a double-blind, detailed functional analysis of the vesical emptying stage over the course of 2 years, and did not simply comprise an evaluation of clinical parameters and uroflowmetrics. We saw a reduction of infravesical obstruction, as shown by the significant reduction of ≥20 cm H(2)O in the mean micturition pressure for the groups studied, as well as a significant reduction in bladder outlet obstruction index. Thus, the present data show that high-power PVP can achieve and maintain the same results as TURP over a period of 24 months regarding an aspect that is particularly important for maintaining vesical health (i.e. detrusor pressure during the evacuation of the bladder). Such urodynamic data describing the functional outcome of PVP are currently missing from the literature.UNLABELLEDWhat's known on the subject? and What does the study add? Photovaporization of the prostate (PVP) is now challenging TURP as the standard treatment for lower LUTS caused by BPH. The learning curve for PVP is short and the main advantages of this method over TURP are a shorter period of hospitalization, a shorter period of postoperative vesical catheterization, lower levels of retrograde ejaculation, rare development of dilutional hyponatraemia syndrome, the lack of a need for postoperative vesical irrigation as a result of extremely low indices of postoperative haematuria, and the lack of a need to suspend anticoagulant medication for the surgery. Traditionally, comparisons of the effectiveness of TURP vs PVP have involved parameters such as peak flow urinary rate and post-void residual urine volume measurements, and have employed questionnaires such as the IPSS and the International Index of Erectile Function instruments. However, studies evaluating detailed urodynamic parameters remain scarce and non-comparative The present study compared postoperative, medium-term urodynamic parameters among patients receiving TURP and high-power PVP. We consider the present study to be distinctive because it involved a double-blind, detailed functional analysis of the vesical emptying stage over the course of 2 years, and did not simply comprise an evaluation of clinical parameters and uroflowmetrics. We saw a reduction of infravesical obstruction, as shown by the significant reduction of ≥20 cm H(2)O in the mean micturition pressure for the groups studied, as well as a significant reduction in bladder outlet obstruction index. Thus, the present data show that high-power PVP can achieve and maintain the same results as TURP over a period of 24 months regarding an aspect that is particularly important for maintaining vesical health (i.e. detrusor pressure during the evacuation of the bladder). Such urodynamic data describing the functional outcome of PVP are currently missing from the literature.To assess the impact of GreenLight HPS™ 120-W (American Medical System Incorporation, Minnetonka, MN, USA) laser photovaporization of the prostate (PVP) compared to transurethral resection of the prostate (TURP) on urodynamic results, voiding function and sexual function.OBJECTIVETo assess the impact of GreenLight HPS™ 120-W (American Medical System Incorporation, Minnetonka, MN, USA) laser photovaporization of the prostate (PVP) compared to transurethral resection of the prostate (TURP) on urodynamic results, voiding function and sexual function.In total, 20 men with intermediate/severe lower urinary tract symptoms as a result of benign prostatic hyperplasia (BPH) were randomly selected and equally divided into two groups: TURP and PVP. Urodynamic evaluation was performed and International Prostate Symptom Score (IPSS), International Index of Erectile Function-5 and International Consultation on Incontinence Questionnaire - Short Form questionnaires were completed. The results were assessed at 2 years.PATIENTS AND METHODSIn total, 20 men with intermediate/severe lower urinary tract symptoms as a result of benign prostatic hyperplasia (BPH) were randomly selected and equally divided into two groups: TURP and PVP. Urodynamic evaluation was performed and International Prostate Symptom Score (IPSS), International Index of Erectile Function-5 and International Consultation on Incontinence Questionnaire - Short Form questionnaires were completed. The results were assessed at 2 years.Mean IPSS scores were reduced in both groups, although they did not differ between the TURP and PVP groups. There was no significant change in International Index of Erectile Function-5 scores. Half of the patients in the PVP group developed urge urinary incontinence with spontaneous resolution. The urodynamic parameters analyzed showed an improvement for both groups, although the values in the TURP group values were not significantly different from those in the PVP group.RESULTSMean IPSS scores were reduced in both groups, although they did not differ between the TURP and PVP groups. There was no significant change in International Index of Erectile Function-5 scores. Half of the patients in the PVP group developed urge urinary incontinence with spontaneous resolution. The urodynamic parameters analyzed showed an improvement for both groups, although the values in the TURP group values were not significantly different from those in the PVP group.Bladder storage symptoms may represent a major concern, although they are of limited duration in patients undergoing PVP. High-power PVP can achieve and maintain the same results as TURP over a period of 24 months.CONCLUSIONSBladder storage symptoms may represent a major concern, although they are of limited duration in patients undergoing PVP. High-power PVP can achieve and maintain the same results as TURP over a period of 24 months.
Study Type – Therapy (RCT) Level of Evidence 1b What's known on the subject? and What does the study add? Photovaporization of the prostate (PVP) is now challenging TURP as the standard treatment for lower LUTS caused by BPH. The learning curve for PVP is short and the main advantages of this method over TURP are a shorter period of hospitalization, a shorter period of postoperative vesical catheterization, lower levels of retrograde ejaculation, rare development of dilutional hyponatraemia syndrome, the lack of a need for postoperative vesical irrigation as a result of extremely low indices of postoperative haematuria, and the lack of a need to suspend anticoagulant medication for the surgery. Traditionally, comparisons of the effectiveness of TURP vs PVP have involved parameters such as peak flow urinary rate and post‐void residual urine volume measurements, and have employed questionnaires such as the IPSS and the International Index of Erectile Function instruments. However, studies evaluating detailed urodynamic parameters remain scarce and non‐comparative The present study compared postoperative, medium‐term urodynamic parameters among patients receiving TURP and high‐power PVP. We consider the present study to be distinctive because it involved a double‐blind, detailed functional analysis of the vesical emptying stage over the course of 2 years, and did not simply comprise an evaluation of clinical parameters and uroflowmetrics. We saw a reduction of infravesical obstruction, as shown by the significant reduction of ≥20 cm H2O in the mean micturition pressure for the groups studied, as well as a significant reduction in bladder outlet obstruction index. Thus, the present data show that high‐power PVP can achieve and maintain the same results as TURP over a period of 24 months regarding an aspect that is particularly important for maintaining vesical health (i.e. detrusor pressure during the evacuation of the bladder). Such urodynamic data describing the functional outcome of PVP are currently missing from the literature. OBJECTIVE •  To assess the impact of GreenLight HPSTM 120‐W (American Medical System Incorporation, Minnetonka, MN, USA) laser photovaporization of the prostate (PVP) compared to transurethral resection of the prostate (TURP) on urodynamic results, voiding function and sexual function. PATIENTS AND METHODS •  In total, 20 men with intermediate/severe lower urinary tract symptoms as a result of benign prostatic hyperplasia (BPH) were randomly selected and equally divided into two groups: TURP and PVP. •  Urodynamic evaluation was performed and International Prostate Symptom Score (IPSS), International Index of Erectile Function‐5 and International Consultation on Incontinence Questionnaire – Short Form questionnaires were completed. •  The results were assessed at 2 years. RESULTS •  Mean IPSS scores were reduced in both groups, although they did not differ between the TURP and PVP groups. •  There was no significant change in International Index of Erectile Function‐5 scores. •  Half of the patients in the PVP group developed urge urinary incontinence with spontaneous resolution. •  The urodynamic parameters analyzed showed an improvement for both groups, although the values in the TURP group values were not significantly different from those in the PVP group. CONCLUSIONS •  Bladder storage symptoms may represent a major concern, although they are of limited duration in patients undergoing PVP. •  High‐power PVP can achieve and maintain the same results as TURP over a period of 24 months.
What's known on the subject? and What does the study add? Photovaporization of the prostate (PVP) is now challenging TURP as the standard treatment for lower LUTS caused by BPH. The learning curve for PVP is short and the main advantages of this method over TURP are a shorter period of hospitalization, a shorter period of postoperative vesical catheterization, lower levels of retrograde ejaculation, rare development of dilutional hyponatraemia syndrome, the lack of a need for postoperative vesical irrigation as a result of extremely low indices of postoperative haematuria, and the lack of a need to suspend anticoagulant medication for the surgery. Traditionally, comparisons of the effectiveness of TURP vs PVP have involved parameters such as peak flow urinary rate and post-void residual urine volume measurements, and have employed questionnaires such as the IPSS and the International Index of Erectile Function instruments. However, studies evaluating detailed urodynamic parameters remain scarce and non-comparative The present study compared postoperative, medium-term urodynamic parameters among patients receiving TURP and high-power PVP. We consider the present study to be distinctive because it involved a double-blind, detailed functional analysis of the vesical emptying stage over the course of 2 years, and did not simply comprise an evaluation of clinical parameters and uroflowmetrics. We saw a reduction of infravesical obstruction, as shown by the significant reduction of ≥20 cm H(2)O in the mean micturition pressure for the groups studied, as well as a significant reduction in bladder outlet obstruction index. Thus, the present data show that high-power PVP can achieve and maintain the same results as TURP over a period of 24 months regarding an aspect that is particularly important for maintaining vesical health (i.e. detrusor pressure during the evacuation of the bladder). Such urodynamic data describing the functional outcome of PVP are currently missing from the literature. To assess the impact of GreenLight HPS™ 120-W (American Medical System Incorporation, Minnetonka, MN, USA) laser photovaporization of the prostate (PVP) compared to transurethral resection of the prostate (TURP) on urodynamic results, voiding function and sexual function. In total, 20 men with intermediate/severe lower urinary tract symptoms as a result of benign prostatic hyperplasia (BPH) were randomly selected and equally divided into two groups: TURP and PVP. Urodynamic evaluation was performed and International Prostate Symptom Score (IPSS), International Index of Erectile Function-5 and International Consultation on Incontinence Questionnaire - Short Form questionnaires were completed. The results were assessed at 2 years. Mean IPSS scores were reduced in both groups, although they did not differ between the TURP and PVP groups. There was no significant change in International Index of Erectile Function-5 scores. Half of the patients in the PVP group developed urge urinary incontinence with spontaneous resolution. The urodynamic parameters analyzed showed an improvement for both groups, although the values in the TURP group values were not significantly different from those in the PVP group. Bladder storage symptoms may represent a major concern, although they are of limited duration in patients undergoing PVP. High-power PVP can achieve and maintain the same results as TURP over a period of 24 months.
Author Muller, Valter José Fernandes
Krambeck, Renato Lages
de Moraes Sousa, Karlo Danilson
de Morais Perpétuo, Daniel
Vaz, Fernando Pires
Lopes‐da‐Silva, Luiz Felipe
Pereira‐Correia, João Antonio
Santos, João Bosco Pinheiro
Author_xml – sequence: 1
  givenname: João Antonio
  surname: Pereira‐Correia
  fullname: Pereira‐Correia, João Antonio
– sequence: 2
  givenname: Karlo Danilson
  surname: de Moraes Sousa
  fullname: de Moraes Sousa, Karlo Danilson
– sequence: 3
  givenname: João Bosco Pinheiro
  surname: Santos
  fullname: Santos, João Bosco Pinheiro
– sequence: 4
  givenname: Daniel
  surname: de Morais Perpétuo
  fullname: de Morais Perpétuo, Daniel
– sequence: 5
  givenname: Luiz Felipe
  surname: Lopes‐da‐Silva
  fullname: Lopes‐da‐Silva, Luiz Felipe
– sequence: 6
  givenname: Renato Lages
  surname: Krambeck
  fullname: Krambeck, Renato Lages
– sequence: 7
  givenname: Valter José Fernandes
  surname: Muller
  fullname: Muller, Valter José Fernandes
– sequence: 8
  givenname: Fernando Pires
  surname: Vaz
  fullname: Vaz, Fernando Pires
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26569938$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/22257240$$D View this record in MEDLINE/PubMed
BookMark eNqVUUtuFDEUtFAQ-cAVkDdIYTGDf_1DKBJEkIBGAgki2Fke-znjkbt7sLuHTFZIcADOwJ5L5SS4O5MgsQJv_ORXVe-5ah_tNG0DCGFKpjSdJ8spFbmYCEo-TRmhdEpJWZTTizto77axc1OTKt9F-zEuCUkPeXYP7TLGsoIJsod-nQSAZubOFx0-fff-6vtPTBm5-vrjI_YqQsBrtWqDu1Sdaxu8jrgLqol9gG4RlMcBIuix1VrcLQCvQhs71QE-fJYnmW_17PFTrDBLihtQASe2aWt3CQabtp97SI25d40ZmatBbA24D63ZNKp2GrtmDbFz5-MC99Fdq3yEB9v7AJ29evnh-HQye3vy-vj5bKLTB8sJqFyoygDnhCmjCNdCMAuCMqq4MCXYPNMF5aALm9ypSKXE3NhMWJ0JXVl-gA6vddNSn_s0X9YuavBeNdD2USa7aVlwXhUJ-nAL7ec1GLkKrlZhI28sToBHW4CKWnmbHNAu_sHlWV5VvEy48hqnkxExgL2FUCKH1OVSDoHKIVw5pC7H1OVFoh79RdWuGw1LaTn_HwJfnIfNPw-WL96cjSX_DVA8zbU
CitedBy_id crossref_primary_10_1007_s00120_012_3087_z
crossref_primary_10_1007_s11930_018_0172_3
crossref_primary_10_1016_j_eururo_2013_03_004
crossref_primary_10_1016_j_eururo_2024_04_031
crossref_primary_10_1111_bju_13479
crossref_primary_10_1002_smrj_20
crossref_primary_10_1186_s12894_015_0029_2
crossref_primary_10_1016_j_eururo_2012_04_051
crossref_primary_10_1007_s11934_015_0525_7
crossref_primary_10_1177_1756287216632429
crossref_primary_10_1590_1806_9282_63_11_929
crossref_primary_10_1159_000356991
crossref_primary_10_5534_wjmh_2016_34_2_110
crossref_primary_10_1016_j_eururo_2014_06_017
crossref_primary_10_1007_s10103_015_1721_x
crossref_primary_10_1007_s11884_021_00627_2
crossref_primary_10_1089_end_2012_0136
crossref_primary_10_1016_j_urology_2015_06_024
crossref_primary_10_1089_end_2022_0222
crossref_primary_10_1007_s11934_018_0838_4
crossref_primary_10_1016_j_urology_2014_06_027
crossref_primary_10_1007_s00345_015_1635_z
crossref_primary_10_1038_nrurol_2014_23
crossref_primary_10_1007_s11884_015_0294_7
crossref_primary_10_1590_1806_9282_2024d708
crossref_primary_10_1016_j_euf_2022_06_007
crossref_primary_10_3109_21681805_2012_759272
crossref_primary_10_1002_lsm_22240
crossref_primary_10_1016_j_purol_2013_10_003
crossref_primary_10_1097_MOU_0000000000000124
crossref_primary_10_1016_j_eururo_2021_04_012
crossref_primary_10_1136_bmjopen_2018_028855
crossref_primary_10_1007_s10103_012_1235_8
crossref_primary_10_1089_end_2015_0202
crossref_primary_10_1007_s12325_017_0504_0
crossref_primary_10_1007_s00120_015_3983_0
crossref_primary_10_1111_j_1464_410X_2012_10354_x
crossref_primary_10_1007_s00345_024_05439_7
crossref_primary_10_1007_s00345_014_1437_8
crossref_primary_10_1089_end_2013_0715
crossref_primary_10_1007_s10103_023_03794_2
crossref_primary_10_1089_pho_2016_4237
crossref_primary_10_1016_j_purol_2018_07_287
crossref_primary_10_2147_RRU_S277482
crossref_primary_10_23736_S2724_6051_24_05802_6
crossref_primary_10_1007_s00345_013_1203_3
crossref_primary_10_1016_j_purol_2013_03_021
crossref_primary_10_3389_fsurg_2021_705105
crossref_primary_10_1111_jsm_12044
crossref_primary_10_1007_s00345_024_05332_3
crossref_primary_10_1007_s10103_015_1843_1
crossref_primary_10_4111_icu_2019_60_6_480
crossref_primary_10_1016_j_urology_2012_11_042
crossref_primary_10_1016_j_urology_2023_12_018
crossref_primary_10_1016_j_purol_2020_12_006
crossref_primary_10_1371_journal_pone_0184442
crossref_primary_10_1007_s10103_013_1320_7
crossref_primary_10_1016_j_jval_2015_04_002
crossref_primary_10_1007_s11934_018_0813_0
crossref_primary_10_1007_s11934_013_0351_8
crossref_primary_10_2530_jslsm_jslsm_35_0039
crossref_primary_10_1016_j_jvir_2021_06_019
crossref_primary_10_1097_MOU_0000000000000500
crossref_primary_10_1038_srep23503
crossref_primary_10_1016_j_ucl_2016_04_006
crossref_primary_10_1039_c8pp00409a
crossref_primary_10_1007_s00345_013_1103_6
crossref_primary_10_1111_j_1464_410X_2012_10354_2_x
Cites_doi 10.1097/01.ju.0000128803.04158.76
10.1016/j.eururo.2008.05.003
10.1016/j.urology.2007.01.042
10.1016/j.urology.2009.08.015
10.1590/S1677-55382010000200009
10.1016/j.eururo.2005.07.001
10.1111/j.1464-410X.2008.07905.x
10.1016/S0090-4295(94)80170-3
10.1097/01.ju.0000139541.68542.f6
10.1038/sj.pcan.4500949
10.1089/end.2006.20.580
10.1097/01.ju.0000146631.14200.d4
10.1016/j.urology.2007.09.017
10.1002/nau.10066
10.1097/00042307-200401000-00006
10.1097/00042307-200401000-00005
10.1016/j.eururo.2006.08.006
10.1016/S0022-5347(05)67530-1
10.1089/end.2007.0321
10.1016/j.eursup.2007.11.004
10.1016/j.eururo.2011.05.043
10.1007/BF00182664
10.1016/j.eursup.2008.01.014
10.1016/j.eururo.2010.05.026
10.1016/j.eursup.2008.01.013
10.1016/j.eursup.2008.01.016
ContentType Journal Article
Copyright 2012 BJU INTERNATIONAL
2015 INIST-CNRS
2012 BJU INTERNATIONAL.
Copyright_xml – notice: 2012 BJU INTERNATIONAL
– notice: 2015 INIST-CNRS
– notice: 2012 BJU INTERNATIONAL.
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1111/j.1464-410X.2011.10878.x
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1464-410X
EndPage 1189
ExternalDocumentID 22257240
26569938
10_1111_j_1464_410X_2011_10878_x
BJU10878
Genre article
Randomized Controlled Trial
Journal Article
Comparative Study
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
1OC
23N
24P
2WC
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
6P2
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACUHS
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BAWUL
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HZI
HZ~
IHE
IX1
J0M
J5H
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
R.K
RJQFR
ROL
RX1
SUPJJ
SV3
TEORI
TUS
UB1
V9Y
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
X7M
XG1
YFH
ZGI
ZXP
~IA
~WT
AAMMB
AAYXX
AEFGJ
AEYWJ
AGHNM
AGXDD
AGYGG
AIDQK
AIDYY
AIQQE
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c4668-ea64a9de3302ada03c442fe4121a34d8ef65c713ec7f096909a4bdf54fc54c9f3
IEDL.DBID DR2
ISSN 1464-4096
1464-410X
IngestDate Thu Oct 02 10:53:27 EDT 2025
Thu Apr 03 07:08:23 EDT 2025
Mon Jul 21 09:13:21 EDT 2025
Thu Apr 24 23:44:10 EDT 2025
Wed Oct 01 04:28:53 EDT 2025
Wed Jan 22 16:41:18 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Nephrology
photovaporization
Surgical resection
Transurethral route
Urology
Vaporization
Prospective
Urodynamics
Randomization
Treatment
transurethral resection of prostate
Surgery
Laser
GreenLight laser
Surgical approach
urodynamic
Urogenital system
Prostate
Comparative study
Language English
License CC BY 4.0
2012 BJU INTERNATIONAL.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4668-ea64a9de3302ada03c442fe4121a34d8ef65c713ec7f096909a4bdf54fc54c9f3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
PMID 22257240
PQID 1081873397
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_1081873397
pubmed_primary_22257240
pascalfrancis_primary_26569938
crossref_primary_10_1111_j_1464_410X_2011_10878_x
crossref_citationtrail_10_1111_j_1464_410X_2011_10878_x
wiley_primary_10_1111_j_1464_410X_2011_10878_x_BJU10878
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate October 2012
PublicationDateYYYYMMDD 2012-10-01
PublicationDate_xml – month: 10
  year: 2012
  text: October 2012
PublicationDecade 2010
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: Oxford
– name: England
PublicationTitle BJU international
PublicationTitleAlternate BJU Int
PublicationYear 2012
Publisher Blackwell Publishing Ltd
Wiley-Blackwell
Publisher_xml – name: Blackwell Publishing Ltd
– name: Wiley-Blackwell
References 2010; 75
2005; 173
2010; 36
2010; 58
1995; 13
2011; 60
2006; 8
1994; 44
2008; 7
2008; 54
2007; 51
2008; 102
2005; 48
2007; 10
2008; 71
2007; 14
2009; 33
2006; 20
2004; 14
2002; 21
2004; 172
2004; 171
2000; 163
2008; 22
2007; 69
e_1_2_7_5_2
e_1_2_7_4_2
e_1_2_7_2_2
e_1_2_7_9_2
e_1_2_7_8_2
Matoka DJ (e_1_2_7_30_2) 2007; 14
e_1_2_7_7_2
e_1_2_7_6_2
e_1_2_7_19_2
e_1_2_7_17_2
e_1_2_7_16_2
e_1_2_7_15_2
e_1_2_7_14_2
e_1_2_7_13_2
e_1_2_7_12_2
e_1_2_7_11_2
e_1_2_7_10_2
Manjón CC (e_1_2_7_18_2) 2009; 33
e_1_2_7_26_2
e_1_2_7_27_2
e_1_2_7_28_2
e_1_2_7_29_2
Reich O (e_1_2_7_20_2) 2005; 173
Te AE (e_1_2_7_3_2) 2006; 8
e_1_2_7_25_2
e_1_2_7_24_2
e_1_2_7_23_2
e_1_2_7_31_2
e_1_2_7_22_2
e_1_2_7_21_2
References_xml – volume: 71
  start-page: 247
  year: 2008
  end-page: 51
  article-title: Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: a short‐term prospective randomized trial
  publication-title: Urology
– volume: 54
  start-page: 902
  year: 2008
  end-page: 10
  article-title: Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow‐up
  publication-title: Eur Urol
– volume: 21
  start-page: 261
  year: 2002
  end-page: 74
  article-title: Good urodynamic practices: uroflowmetry, filling cystometry, and pressure‐flow studies
  publication-title: Neurourol Urodyn
– volume: 171
  start-page: 2502
  year: 2004
  end-page: 4
  article-title: Experimental comparison of high‐power (80W) potassiumtitanyl phosphate laser vaporization and transurethral resection of the prostate
  publication-title: J Urol
– volume: 7
  start-page: 384
  year: 2008
  end-page: 92
  article-title: GreenLight HPS 120‐W laser for benign prostatic hyperplasia: comparative complications and technical recommendations
  publication-title: Eur Urol. Suppl.
– volume: 22
  start-page: 1519
  year: 2008
  end-page: 25
  article-title: Comparison of photoselective vaporization of the prostate and transurethral resection of the prostate: a prospective nonrandomized bicenter trial with 2‐year follow‐up
  publication-title: J Endourol
– volume: 48
  start-page: 965
  year: 2005
  end-page: 72
  article-title: Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi‐centre study of perioperative morbidity and early funcional outcome
  publication-title: Eur Urol
– volume: 7
  start-page: 361
  year: 2008
  end-page: 2
  article-title: GreenLight HPS Laser therapy for BPH: clinical outcomes and surgical recommendations from the International GreenLight user (IGLU) group
  publication-title: Eur Urol Suppl
– volume: 44
  start-page: 856
  year: 1994
  end-page: 61
  article-title: The optimization of laser prostatectomy part II: other lasing techniques
  publication-title: Urology
– volume: 20
  start-page: 580
  year: 2006
  end-page: 5
  article-title: KTP laser versus transurethral resection: early results of a randomized trial
  publication-title: J Endourol
– volume: 14
  start-page: 21
  year: 2004
  end-page: 5
  article-title: High‐power KTP laser prostatectomy: the new challenge to transurethral resection of the prostate
  publication-title: Curr Opin Urol
– volume: 13
  start-page: 34
  year: 1995
  end-page: 9
  article-title: The Abrams–Griffiths nomogram
  publication-title: World J Urol
– volume: 14
  start-page: 3710
  year: 2007
  end-page: 4
  article-title: Predictability of irritative voiding symptoms following phtoselective laser vaporization of the prostate
  publication-title: Can J Urol
– volume: 172
  start-page: 1404
  year: 2004
  end-page: 8
  article-title: Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12‐month results from The First United States Multicenter Prospective Trial
  publication-title: J Urol
– volume: 8
  start-page: S24
  issue: 3
  year: 2006
  end-page: 30
  article-title: The next generation in laser treatments and the role of the GreenLight high‐performance system laser
  publication-title: Rev Urol
– volume: 60
  start-page: 734
  year: 2011
  end-page: 9
  article-title: Green‐light HPS 120‐W laser vaporization versus transurethral resection of the prostate for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2‐year follow‐up
  publication-title: Eur Urol
– volume: 102
  start-page: 1432
  year: 2008
  end-page: 8
  article-title: Comparison of potassium‐titanyl‐phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective nonrandomized two‐centre study
  publication-title: BJU Int
– volume: 54
  start-page: 902
  year: 2008
  end-page: 7
  article-title: Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow‐up
  publication-title: Eur Urol
– volume: 33
  start-page: 771
  year: 2009
  end-page: 7
  article-title: Photoselective vaporization of the prostate with Laser Greenlight HPS: current role, technical aspects and review of the literature
  publication-title: Actas Urol Esp
– volume: 36
  start-page: 190
  year: 2010
  end-page: 7
  article-title: Photoselective vaporazotion of the prostate in men with a history of chronic oral anti‐coagulation
  publication-title: Int Braz J Urol
– volume: 10
  start-page: S2
  year: 2007
  end-page: 5
  article-title: Current state of the art photoselective vaporization prostatectomy: laser therapy for benign prostatic hyperplasia
  publication-title: Prostate Cancer Prostatic Dis
– volume: 163
  start-page: 1730
  year: 2000
  end-page: 3
  article-title: High power potassium‐titanyl‐phosphate laser vaporization prostatectomy
  publication-title: J Urol
– volume: 14
  start-page: 27
  year: 2004
  end-page: 9
  article-title: Could the latest generation potassium titanyl phosphate lasers be the ones to make transurethral resection of the prostate an operation of historical interest only?
  publication-title: Curr Opin Urol
– volume: 7
  start-page: 378
  year: 2008
  end-page: 83
  article-title: Outcome of GreenLight HPS 120‐W laser therapy in specific patient populations: those in retention, on anticoagulants, and with large prostates (≥80 mL)
  publication-title: Eur Urol Suppl
– volume: 58
  start-page: 349
  year: 2010
  end-page: 55
  article-title: Green‐light HPS 120‐W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow‐up
  publication-title: Eur Urol
– volume: 173
  start-page: 158
  year: 2005
  end-page: 60
  article-title: High power (80 W) potassium‐titanylphosphate laser vaporization of the prostate in 66 high risk patients
  publication-title: J Urol
– volume: 51
  start-page: 1031
  year: 2007
  end-page: 41
  article-title: Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation
  publication-title: Eur Urol
– volume: 7
  start-page: 363
  year: 2008
  end-page: 9
  article-title: Historical aspects of laser therapy for benign prostatic hyperplasia
  publication-title: Eur Urol Suppl
– volume: 75
  start-page: 1015
  year: 2010
  end-page: 22
  article-title: Systematic review and meta‐analysis of transurethral resection of the prostate versus minimally invasive procedures for the treatment of benign prostatic obstruction
  publication-title: Urology
– volume: 69
  start-page: 859
  year: 2007
  end-page: 63
  article-title: Influence of bladder contractility on short‐term outcomes of high‐power potassium‐titanyl‐phosphate photoselective vaporization of the prostate
  publication-title: Urology
– ident: e_1_2_7_29_2
  doi: 10.1097/01.ju.0000128803.04158.76
– ident: e_1_2_7_12_2
  doi: 10.1016/j.eururo.2008.05.003
– ident: e_1_2_7_13_2
  doi: 10.1016/j.urology.2007.01.042
– ident: e_1_2_7_28_2
  doi: 10.1016/j.eururo.2008.05.003
– ident: e_1_2_7_19_2
  doi: 10.1016/j.urology.2009.08.015
– ident: e_1_2_7_21_2
  doi: 10.1590/S1677-55382010000200009
– ident: e_1_2_7_7_2
  doi: 10.1016/j.eururo.2005.07.001
– ident: e_1_2_7_9_2
  doi: 10.1111/j.1464-410X.2008.07905.x
– ident: e_1_2_7_31_2
  doi: 10.1016/S0090-4295(94)80170-3
– ident: e_1_2_7_17_2
  doi: 10.1097/01.ju.0000139541.68542.f6
– ident: e_1_2_7_6_2
  doi: 10.1038/sj.pcan.4500949
– ident: e_1_2_7_8_2
  doi: 10.1089/end.2006.20.580
– volume: 173
  start-page: 158
  year: 2005
  ident: e_1_2_7_20_2
  article-title: High power (80 W) potassium‐titanylphosphate laser vaporization of the prostate in 66 high risk patients
  publication-title: J Urol
  doi: 10.1097/01.ju.0000146631.14200.d4
– ident: e_1_2_7_11_2
  doi: 10.1016/j.urology.2007.09.017
– volume: 14
  start-page: 3710
  year: 2007
  ident: e_1_2_7_30_2
  article-title: Predictability of irritative voiding symptoms following phtoselective laser vaporization of the prostate
  publication-title: Can J Urol
– ident: e_1_2_7_14_2
  doi: 10.1002/nau.10066
– ident: e_1_2_7_5_2
  doi: 10.1097/00042307-200401000-00006
– ident: e_1_2_7_4_2
  doi: 10.1097/00042307-200401000-00005
– ident: e_1_2_7_24_2
  doi: 10.1016/j.eururo.2006.08.006
– ident: e_1_2_7_16_2
  doi: 10.1016/S0022-5347(05)67530-1
– ident: e_1_2_7_10_2
  doi: 10.1089/end.2007.0321
– ident: e_1_2_7_23_2
  doi: 10.1016/j.eursup.2007.11.004
– ident: e_1_2_7_27_2
  doi: 10.1016/j.eururo.2011.05.043
– ident: e_1_2_7_15_2
  doi: 10.1007/BF00182664
– volume: 33
  start-page: 771
  year: 2009
  ident: e_1_2_7_18_2
  article-title: Photoselective vaporization of the prostate with Laser Greenlight HPS: current role, technical aspects and review of the literature
  publication-title: Actas Urol Esp
– ident: e_1_2_7_2_2
  doi: 10.1016/j.eursup.2008.01.014
– ident: e_1_2_7_26_2
  doi: 10.1016/j.eururo.2010.05.026
– volume: 8
  start-page: S24
  issue: 3
  year: 2006
  ident: e_1_2_7_3_2
  article-title: The next generation in laser treatments and the role of the GreenLight high‐performance system laser
  publication-title: Rev Urol
– ident: e_1_2_7_22_2
  doi: 10.1016/j.eursup.2008.01.013
– ident: e_1_2_7_25_2
  doi: 10.1016/j.eursup.2008.01.016
SSID ssj0014665
Score 2.319352
Snippet Study Type – Therapy (RCT) Level of Evidence 1b What's known on the subject? and What does the study add? Photovaporization of the prostate (PVP) is now...
What's known on the subject? and What does the study add? Photovaporization of the prostate (PVP) is now challenging TURP as the standard treatment for lower...
SourceID proquest
pubmed
pascalfrancis
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1184
SubjectTerms Aged
Biological and medical sciences
Double-Blind Method
GreenLight laser
Humans
Laser Therapy
Male
Medical sciences
Middle Aged
Nephrology. Urinary tract diseases
photovaporization
prostate
Prostate - surgery
Prostatic Hyperplasia - physiopathology
Prostatic Hyperplasia - surgery
Transurethral Resection of Prostate
urodynamic
Urodynamics
Title GreenLight HPS™ 120‐W laser vaporization vs transurethral resection of the prostate (<60 mL): a 2‐year randomized double‐blind prospective urodynamic investigation
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1464-410X.2011.10878.x
https://www.ncbi.nlm.nih.gov/pubmed/22257240
https://www.proquest.com/docview/1081873397
Volume 110
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVEBS
  databaseName: Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 1464-410X
  dateEnd: 20241101
  omitProxy: true
  ssIdentifier: ssj0014665
  issn: 1464-4096
  databaseCode: ABDBF
  dateStart: 19990101
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1464-410X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0014665
  issn: 1464-4096
  databaseCode: DIK
  dateStart: 19990101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVWIB
  databaseName: Wiley Online Library - Core collection (SURFmarket)
  issn: 1464-4096
  databaseCode: DR2
  dateStart: 19970101
  customDbUrl:
  isFulltext: true
  eissn: 1464-410X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0014665
  providerName: Wiley-Blackwell
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Pa9RAFB-kBxFE6_-1WkbwoIcsmcxsJhEvVSxLaUXUxb2F-UuXdpNlNym2p0L9AH6G3v1S_SS-mcluSemhiLeQ5D3y8t6b-b3k_UHoNZE2VlxBpKqZiRhoPcqVJlHGrIYlUwLIcIHi3ud0OGI748G4zX9ytTChP8Tqg5vzDL9eOwcXcnHVyVnESDwOnThJnPGs7_AkoamPrr6uOknBrX6qZCAB2N5N6rmWUWenujsTC3hpNky7uA6OdtGt356276ODpWAhK-Wg39Syr06u9Hz8P5Kvo3stisVbweweoFumfIhu77X_6R-hPz6dZ9cF_nj45dvFr3NMkvji9PcPDGjdzPGRANzfloDiowWu3ZbZzE29Pwe-riTK11vgymJAqHjmalMAFeM371NgczbdffsOC5wAx2NwVQzUuppOTozGumrkoYELEgTVnrItJsUNbBbHpZhOFJ5cthepysdotP3p-8dh1A6GiBToMYuMSJnItaE0ToQWMVWMJdYwkhBBmc6MTQcKom-juAVd53EumNR2wKwaMJVb-gStlVVpniHMuOI8jXMKfFgGYAviMZvKRFPDdSxYD_GlERSq7ZruhnccFp3oiRVOG4XTRuG1UfzsIbKinIXOITeg2ezY2YowAdgNSDLroVdLwytgHXA_d0RpqmbhOJCMU4CXPfQ0WOQlNSzaHKAbCOPt6sbPU3zYGfnD5_9MuYHuwPkk5D--QGv1vDEvAcfVctN76F-4nj6L
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQIgES4g1bHouROMAhlZ24cYK48FqVpV0h2IreIscPUW2bVG2yYveEBD-A38CdP7W_hLGddpXVHlaIW5RkRpnMjP2N7ZlB6CnNDZFcQqSqmA4YaD1IpaJBwoyCITMHkGEDxeFu3B-xnXFv3LQDsrkwvj7EesHNeoYbr62D2wXp017OAkbJ2JfipCThSRcA5UW4T6yJv_20riUF77q-kp4GgHv7WM-ZnFpz1dW5WMJvM77fxVmAtI1v3QS1fR1NV6L5cyn73brKu_LoVNXH_yT7DXStAbL4lbe8m-iCLm6hS8Nmq_42-uNO9Axs7I_7Hz8f__yNaUiOv__6ggGw6wU-EAD9myxQfLDElZ0164Wuvi6Ar82KcikXuDQYQCqe2_QUAMb42csY2PyYDZ6_wAKHwPEQvBUDtSpnkyOtsCrrfKrhQQ6SKkfZ5JPiGuaLw0LMJhJPTiqMlMUdNNp-t_emHzS9IQIJikwCLWImUqWjiIRCCRJJxkKjGQ2piJhKtIl7EgJwLbkBZackFSxXpseM7DGZmugu2ijKQm8izLjkPCZpBHxYAngLQjIT56GKNFdEsA7iKyvIZFM43fbvmGatAIplVhuZ1UbmtJF96yC6ppz74iHnoNlqGdqaMATkDWAy6aAnK8vLYCiw-zui0GW9tBxowiNAmB10z5vkCTWM2xzQGwjjDOvc35O93hm5y_v_TPkYXe7vDQfZ4P3uhwfoCrwT-uOQD9FGtaj1I4B1Vb7l3PUvl6xCrA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF6hVqqQEG9KKLSLxAEOjvwYe23EBWijUNKqAiJys9b7EBGJHSV2RXtCgh_Ab-DOn-ovYXbtpHLVQ4W4WbJn5PU89hvvPAh55mXaFUxgpCpBOYBSdxIhPScGLdFlZggyTKB4cBj1h7A_CkfNOCBTC1P3h1j9cDOWYf21MXA1k_qilYMDnjuqW3F6bsziLgLKdQiT2OT37X5Y9ZLCZ-1cyZoGgXs7redSTq296saML_Cz6XrexWWAtI1v7QbVu0Umy6XVeSlfu1WZdcXpha6P_2ntt8nNBsjS17Xm3SHXVH6XbBw0R_X3yB-b0TMwsT_tH308-_mber579v3XZ4qAXc3pMUfo31SB0uMFLc2uWc1V-WWOfE1VlC25oIWmCFLpzJSnIDCmz19FyObHdPDiJeXUR44naK0UqWUxHZ8qSWVRZROFNzJcqbSUTT0prXC_OMn5dCzo-LzDSJHfJ8Pe3qe3faeZDeEIFGTsKB4BT6QKAtfnkruBAPC1As_3eAAyVjoKBQbgSjCNwk7chEMmdQhahCASHTwga3mRq4eEAhOMRW4SIB-IEW9hSKajzJeBYtLl0CFsqQWpaBqnm_kdk7QVQEFqpJEaaaRWGum3DvFWlLO6ecgVaLZbirYi9BF5I5iMO-TpUvNSdAXmfIfnqqgWhoMXswARZods1ip5To1-myF6w8VYxbry-6Rv9of28tE_U-6QjaPdXjp4d_h-i1zHR_w6G_IxWSvnlXqCqK7Mtq21_gXllkIw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=GreenLight+HPS%E2%84%A2+120-W+laser+vaporization+vs+transurethral+resection+of+the+prostate+%28%3C60+mL%29%3A+a+2-year+randomized+double-blind+prospective+urodynamic+investigation&rft.jtitle=BJU+international&rft.au=Pereira-Correia%2C+Jo%C3%A3o+Antonio&rft.au=de+Moraes+Sousa%2C+Karlo+Danilson&rft.au=Santos%2C+Jo%C3%A3o+Bosco+Pinheiro&rft.au=de+Morais+Perp%C3%A9tuo%2C+Daniel&rft.date=2012-10-01&rft.issn=1464-410X&rft.eissn=1464-410X&rft.volume=110&rft.issue=8&rft.spage=1184&rft_id=info:doi/10.1111%2Fj.1464-410X.2011.10878.x&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1464-4096&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1464-4096&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1464-4096&client=summon